Page 27 - Bio Developments News Today

The Cell and Gene Therapy Catapult (CGT Catapult) has opened its facility in the Edinburgh BioQuarter, its first site in Scotland.

Axol Bioscience Ltd, a pluripotent stem cell technology provider for drug discovery, has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s Disease (AD) patient samples.

Back in May, Cytiva completed its integration with Pall Life Sciences, a move that CEO Emmanuel Ligner now describes as a “winning recipe” which has improved the company’s supply chain and fostered industry collaboration.

Veeva has announced the expansion of its business consulting services to help life sciences organizations achieve “greater speed and efficiency” across the product development lifecycle.

BenevolentAI, a clinical-stage AI development company, has announced the successful delivery of its pre-clinical candidate for the potential treatment of amyotrophic lateral sclerosis (ALS), BEN-34712.

Providence Therapeutics, a biopharmaceutical company developing mRNA vaccines and therapeutics, has announced its partnership with with University Health Network (UHN).

CDMO Wheeler Bio, Inc. has welcomed Charles River’s flexible biologics testing lab, RightSource, to its Oklahoma City drug substance manufacturing site.

InvoX Pharma has completed a second tranche of investment of pHion Therapeutics, a next-generation mRNA vaccine company.

Lifebit and Flatiron Health have announced a multi-year strategic partnership to support cancer research and enable scientific discoveries.

MRNA technology is a “game-changer” for Asia-Pacific (APAC) vaccine manufacturers, according to a new report by science and technology company Merck.